QLARIS BIO Trademark

Trademark Overview

On Friday, September 20, 2019, a trademark application was filed for QLARIS BIO with the United States Patent and Trademark Office. The USPTO has given the QLARIS BIO trademark a serial number of 88625266. The federal status of this trademark filing is REGISTERED as of Tuesday, March 8, 2022. This trademark is owned by Qlaris Bio, Inc.. The QLARIS BIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research; Research and development in the field of pharmaceuticals, therapeutics, drug formulation and delivery; Research and development in the pharmaceutical and biotechnology fields; Scientific research; Biochemical research and development; Clinical research in the field of pharmaceuticals, therapeutics, drug formulation and delivery; Pharmaceutical research and development; Product research and development; Scientific research and development
qlaris bio

General Information

Serial Number88625266
Word MarkQLARIS BIO
Filing DateFriday, September 20, 2019
Status700 - REGISTERED
Status DateTuesday, March 8, 2022
Registration Number6662146
Registration DateTuesday, March 8, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 5, 2020

Trademark Statements

Disclaimer with Predetermined Text"BIO"
Goods and ServicesMedical research; Research and development in the field of pharmaceuticals, therapeutics, drug formulation and delivery; Research and development in the pharmaceutical and biotechnology fields; Scientific research; Biochemical research and development; Clinical research in the field of pharmaceuticals, therapeutics, drug formulation and delivery; Pharmaceutical research and development; Product research and development; Scientific research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 26, 2019
Primary Code042
First Use Anywhere DateTuesday, August 13, 2019
First Use In Commerce DateMonday, August 26, 2019

Trademark Owner History

Party NameQlaris Bio, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWellesley, MA 02481
Party NameQlaris Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaban, MA 02468
Party NameQlaris Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaban, MA 02468

Trademark Events

Event DateEvent Description
Friday, July 22, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 22, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 8, 2022REGISTERED-PRINCIPAL REGISTER
Friday, January 28, 20221(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, December 23, 2021NOTICE OF ALLOWANCE CANCELLED
Friday, January 28, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 23, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, September 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 22, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, September 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, June 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 10, 2021SOU EXTENSION 2 GRANTED
Thursday, June 10, 2021SOU EXTENSION 2 FILED
Thursday, June 10, 2021TEAS EXTENSION RECEIVED
Wednesday, December 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 21, 2020SOU EXTENSION 1 GRANTED
Monday, December 21, 2020SOU EXTENSION 1 FILED
Monday, December 21, 2020TEAS EXTENSION RECEIVED
Tuesday, June 30, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 12, 2020CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Friday, June 12, 2020ASSIGNED TO PETITION STAFF
Thursday, May 14, 2020TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, May 5, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 5, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 15, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 30, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 30, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 30, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 25, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 16, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 16, 2020NON-FINAL ACTION E-MAILED
Monday, March 16, 2020NON-FINAL ACTION WRITTEN
Tuesday, February 18, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 18, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 14, 2020ASSIGNED TO LIE
Monday, February 10, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 26, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 26, 2019NON-FINAL ACTION E-MAILED
Thursday, December 26, 2019NON-FINAL ACTION WRITTEN
Thursday, December 19, 2019ASSIGNED TO EXAMINER
Thursday, September 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 24, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

qlaris research development delivery pharmaceutical scientific drug formulation field pharmaceuticals therapeutics